These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26116168)

  • 61. [Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. The experience of Polish lymphoma research group].
    Hołowiecki J; Giebel S; Walewski J; Krawczyk-Kuliś M; Hellmann A; Skotnicki A; Dmoszyńska A; Romejko J; Czyz J; Jurczak W; Kachel Ł; Wojnar J; Stella-Hołowiecka B; Saduś-Wojciechowska M; Sułek K; Jedrzejczak W; Robak T; Mariańska B; Szczylik C; Warzocha K
    Pol Arch Med Wewn; 2003 Aug; 110(2):863-8. PubMed ID: 14682225
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Chevallier P; Labopin M; Milpied N; Bilger K; Socié G; Yakoub-Agha I; Michallet M; Bulabois CE; Maury S; Beguin Y; Bay JO; Blaise D; Maillard N; Guillerm G; Daguindeau E; Raus N; Mohty M
    Bone Marrow Transplant; 2014 Mar; 49(3):361-5. PubMed ID: 24292522
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
    Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
    Leuk Res; 2019 Apr; 79():75-80. PubMed ID: 30654975
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome after hematopoietic stem cell transplantation in patients with extranodal natural killer/T-Cell lymphoma, nasal type: A French study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Philippe Walter L; Couronné L; Jais JP; Nguyen PD; Blaise D; Pigneux A; Socié G; Thieblemont C; Bachy E; Fegueux N; Chevallier P; Mohty M; Yakoub-Agha I; Peffault de Latour R; Jaccard A; Hermine O;
    Am J Hematol; 2021 Jul; 96(7):834-845. PubMed ID: 33864708
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
    Majhail NS; Ness KK; Burns LJ; Sun CL; Carter A; Francisco L; Forman SJ; Bhatia S; Baker KS
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1153-9. PubMed ID: 17889351
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non-hodgkin lymphoma: A retrospective analysis in a resource-limited country.
    Anuar NA; Tey KWF; Ng SC; Teh AKH; Abdul Rahman MHF; Chong BP; Gan GG
    Int J Clin Pract; 2021 Mar; 75(3):e13823. PubMed ID: 33202073
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.
    Smeland KB; Kiserud CE; Lauritzsen GF; Blystad AK; Fagerli UM; Falk RS; Fluge Ø; Fosså A; Kolstad A; Loge JH; Maisenhölder M; Østenstad B; Kvaløy S; Holte H
    Br J Haematol; 2016 May; 173(3):432-43. PubMed ID: 26914167
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis.
    Wudhikarn K; Johnson BM; Inwards DJ; Porrata LF; Micallef IN; Ansell SM; Hogan WJ; Paludo J; Villasboas JC; Johnston PB
    Transplant Cell Ther; 2023 Mar; 29(3):176.e1-176.e8. PubMed ID: 36563788
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine.
    Amer R; Salameh H; Mosleh S; Abu-Taha A; Hamayel H; Enaya A; Adas A; Khursani A; Wild-Ali M; Mousa T; Battat M; Daifallah A; Koni A; Shawahna R
    BMC Infect Dis; 2022 Sep; 22(1):725. PubMed ID: 36071381
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
    Garderet L; Ouldjeriouat H; Bekadja MA; Daguenet E; Bigot N; Vincent L; Roos-Weil D; Vignon M; Ikhlef S; Abraham J; Escoffre-Barbe M; Lioure B; Nacer RA; Lafon I; Mariette C; Karlin L; Morel P; Gilis L; Le Ray E; Blouet A; Nguyen Quoc S; Boffa JJ; Ronco P; Lambert J; Cornillon J
    Br J Haematol; 2024 Apr; 204(4):1450-1458. PubMed ID: 37953476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma.
    Liu W; Wu M; Xie Y; Zhang C; Ping L; Feng F; Leng X; Mi L; Wang X; Zhu J; Song Y
    Leuk Lymphoma; 2021 Feb; 62(2):323-329. PubMed ID: 33054458
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registry.
    Bekadja MA; Boumendil A; Blaise D; Chevallier P; Peggs KS; Salles G; Giebel S; Marks R; Arcese W; Milpied N; Finel H; Gorin NC
    Cytotherapy; 2021 Jun; 23(6):483-487. PubMed ID: 33678598
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Relationship between the absolute lymphocyte count before or after autologous hematopoietic stem cell transplantation and the prognosis in patients with non-Hodgkin's lymphoma].
    Chen J; Wang JM; Zhang WP; Song XM; Qiu HY; Xu XQ; Zhou H; Chen L
    Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):510-4. PubMed ID: 21122327
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).
    Lazarus HM; Carreras J; Boudreau C; Loberiza FR; Armitage JO; Bolwell BJ; Freytes CO; Gale RP; Gibson J; Hale GA; Inwards DJ; LeMaistre CF; Maharaj D; Marks DI; Miller AM; Pavlovsky S; Schouten HC; van Besien K; Vose JM; Bitran JD; Khouri IF; McCarthy PL; Yu H; Rowlings P; Serna DS; Horowitz MM; Rizzo JD;
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1323-33. PubMed ID: 19041053
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Puyade M; Labeyrie C; Badoglio M; Cintas P; Guenounou S; Lansiaux P; Marjanovic Z; Nicolas G; Pomies A; Terriou L; Torregrosa Diaz JM; Baron C; Castilla Llorente C; Yakoub-Agha I; Farge D
    Bull Cancer; 2020 Jan; 107(1S):S104-S113. PubMed ID: 31818426
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
    Majhail NS; Bajorunaite R; Lazarus HM; Wang Z; Klein JP; Zhang MJ; Rizzo JD
    Br J Haematol; 2009 Oct; 147(1):129-39. PubMed ID: 19573079
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
    Hosing C; Saliba RM; Okoroji GJ; Popat U; Couriel D; Ali T; De Padua Silva L; Kebriaei P; Alousi A; De Lima M; Qazilbash M; Anderlini P; Giralt S; Champlin RE; Khouri I
    Ann Oncol; 2008 Jun; 19(6):1166-71. PubMed ID: 18272911
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Salles G; Coiffier B
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):151-69. PubMed ID: 11000990
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Autologous or allogeneic hematopoietic cell transplantation for non-Hodgkin's lymphoma?
    Blume KG
    Ann Hematol; 2002; 81 Suppl 2(Suppl 2):S9-11. PubMed ID: 12611059
    [No Abstract]   [Full Text] [Related]  

  • 80. [Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
    Bull Cancer; 2017 Dec; 104(12S):S131-S135. PubMed ID: 29173980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.